Full Breakdown
Local 12 Medical Reporter Liz Bonis Dies After Four-Year Battle with Colon Cancer
5/2/2026, 2:35:02 AM
Core Event: Death of Liz Bonis
Liz Bonis, the medical reporter for Sinclair Broadcast Group’s WKRC-TV (Local 12) in Cincinnati, died on the evening of Thursday, April 30, 2026. The cause was colon cancer, a disease she had publicly disclosed after an April 2023 diagnosis. Despite undergoing five surgeries and participating in six experimental oncology clinical trials, she continued to file stories until her final days.
Background & Context: Colon Cancer and Clinical Trials
Colon cancer remains a leading cause of cancer mortality in the United States. Clinical trials for novel oncology drugs are a primary pathway for extending survival and improving quality of life for patients with advanced disease. Bonis publicly encouraged participation in such trials, emphasizing their role in advancing treatment options.
Timeline of Diagnosis, Treatment, and Reporting
- April 2023: Bonis receives colon-cancer diagnosis.
- 2023-2026: Undergoes five surgeries to manage disease progression.
- 2023-2026: Enrolls in six separate clinical trials for experimental oncology agents.
- 2023-2026: Continues on-air reporting, covering new medical technologies and cancer therapies.
- April 30, 2026: Passes away at home surrounded by family.
Key Figures & Groups
- Liz Bonis: Medical reporter, advocate for clinical-trial participation.
- Dr. Doug Flora & Dr. Joseph Guenther: Oncologists who oversaw Bonis’s experimental treatments.
- Karen Burke: Member of Bonis’s medical team.
- Franco Gentile: Vice President & General Manager, Local 12, who provided support during her final days.
- James Harrison: Photojournalist and longtime “work-husband” at Local 12.
- Fred Craig: Family spokesperson who issued a public statement on Bonis’s death.
Data & Statistics
- Six clinical trials completed over a four-year period.
- Five surgical interventions performed between 2023 and 2026.
- April 30, 2026: Date of death.
Why It Matters: Impact on Public Health Reporting and Clinical-Trial Advocacy
Bonis’s dual role as a patient and a medical journalist offered a rare, transparent view of experimental cancer treatment. Her on-air coverage of emerging therapies provided viewers with timely information while her personal participation underscored the potential benefits and risks of trial enrollment. The story highlights the influence of journalists in shaping public perception of medical research and may encourage broader community engagement in clinical studies.
Official Statements & Responses
Fred Craig, speaking for Bonis’s family, affirmed that she “encouraged others to participate in medical trials and new medical procedures” and emphasized her commitment to “assist researchers and patients looking for solutions to others’ health challenges.” Local 12’s vice president, Franco Gentile, was described as “especially gracious during her final days,” respecting her wish for confidentiality.
Criticism & Opposition
No critical or opposing viewpoints were reported in the available sources.
Conflicting Reports & Gaps
All reported details are consistent across the source material. The family’s request for privacy limits public disclosure of additional medical specifics or the identities of the experimental drugs involved.
